Leon Caly

6.4k citations
32 papers · 2.6k · 1 hit paper · h-index 15

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • Parasitic Diseases Research and Treatment
    • SARS-CoV-2 detection and testing
  • Virology top 2%
    • Poxvirus research and outbreaks

Papers in

    • Viral Infections and Vectors 7
    • SARS-CoV-2 and COVID-19 Research 7
    • Viral gastroenteritis research and epidemiology 5
    • HIV/AIDS drug development and treatment 3
    • Respiratory viral infections research 9

Leon Caly

30 papers receiving 2.6k citations

Leon Caly's Hit Papers

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro 2020 · 1.5k citations
1.5k0+2+4Years since publication4008001.2k

Peers

Leon Caly
Comparison fields: 5 of 129
  • Infectious Diseases 1.7k
  • Virology 259
  • Applied Microbiology and Biotechnology 48
  • Neurology 285
  • Parasitology 130
Replace Thushan I. de Silva with:
Thushan I. de Silva United Kingdom
Julien Andréani France
Mike Catton Australia
Martin J. Vincent United States
Ali A. Sultan Qatar
Reed F. Johnson United States
Md. Masudur Rahman Bangladesh
Jocelyne Piret Canada
Marilda Mendonça Siqueira Brazil
Aiping Wu China
Leon Caly relative to Thushan I. de Silva United Kingdom Thushan I. de Silva's profile →
Citations per field
00.5×6.8×
Thushan I. de Silva · 1×
Citations per year

Countries citing papers authored by Leon Caly

Since Specialization
Citations

This map shows the geographic impact of Leon Caly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon Caly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon Caly more than expected).

Fields of papers citing papers by Leon Caly

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon Caly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon Caly. The network helps show where Leon Caly may publish in the future.

Co-authors

The 25 scholars most cited alongside Leon Caly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Leon Caly Line = papers co-authored together Leon Caly links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Hit paper breakdown →
20201493
2 2020358
3 2020160
4 2022117
5 201290
6 202265
7 201547
8 200338
9 201434
10 200830
11 202127
12 201824
13 202224
14 201723
15 201914
16 201912
17 201911
18 201810
19 201710
20 201510

About Leon Caly

Leon Caly is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Virology and Public Health, Environmental and Occupational Health, having authored 32 papers that have together received 2.6k indexed citations. Recurring topics across this work include Respiratory viral infections research (9 papers), Viral Infections and Vectors (7 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Mosquito-borne diseases and control (6 papers), Viral gastroenteritis research and epidemiology (5 papers), Animal Virus Infections Studies (5 papers), Poxvirus research and outbreaks (4 papers) and HIV/AIDS drug development and treatment (3 papers). The work is most often cited by research in Infectious Diseases (1.7k citations), Virology (259 citations), Applied Microbiology and Biotechnology (48 citations), Neurology (285 citations) and Parasitology (130 citations). Leon Caly has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include David A. Jans, Julian Druce, Kylie M. Wagstaff, Mike Catton, Tim J. Dalebout, Jutte J.C. de Vries, Ronald W.A.L. Limpens, Jessika C. Zevenhoven-Dobbe, Igor A. Sidorov and Eric J. Snijder. Their work appears in journals such as Viruses, Biochemical and Biophysical Research Communications, The Medical Journal of Australia, Antiviral Research and Emerging infectious diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact